<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000413732">
  <TermName>Telcyta</TermName>
  <TermPronunciation>(tel-SY-tuh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glutathione analogs. Also called TLK286.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713066" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Telcyta&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713065" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Telcyta&quot;" language="es" id="_4"/>
  <SpanishTermName>Telcyta</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de análogo del glutatión. También se llama TLK286.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-03-24</DateFirstPublished>
  <DateLastModified>2005-02-25</DateLastModified>
</GlossaryTerm>
